Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to < b > < i > Calcium Sensing Receptor (CaSR) < /i > < /b > Mutation

Conclusion: This case represents the youngest age at cinacalcet initiation and the longest duration without parathyroidectomy in a homozygous NSHPT and demonstrates that cinacalcet is an effective first-line treatment in patients who are responsive to this treatment modality and allows avoiding/delay in surgical intervention in NSHPT.Horm Res Paediatr
Source: Hormone Research in Paediatrics - Category: Endocrinology Source Type: research